Modulating the oxygen affinity of human fetal haemoglobin with synthetic allosteric modulators

British Journal of Haematology

Volumn 102, Issue 5, 1998, Pages 1165-1171

  Papassotiriou, Ioannis ^a,b   Kister, Jean ^b   Griffon, Nathalie ^b   Stamoulakatou, Alexandra ^a   Abraham, Donald J ^c   Marden, Michael C ^b   Loukopoulos, Dimitris ^d   Poyart, Claude ^b  

^a AGHIA SOPHIA CHILDREN S HOSPITAL   (Greece)

^b INSERM   (France)

^c VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^d UNIVERSITY OF ATHENS   (Greece)

Author keywords

thalassaemia; Allosteric modulators; HbF; HbF acetylated; Tissue oxygenation

Indexed keywords

HEMOGLOBIN;

ALLOSTERISM; ARTICLE; BETA THALASSEMIA; BLOOD TRANSFUSION; CELL SURVIVAL; HEMOGLOBIN SYNTHESIS; HEMOGLOBINOPATHY; HUMAN; HUMAN CELL; MATERNAL BLOOD; OXYGEN AFFINITY; OXYGEN SATURATION; OXYGEN TRANSPORT; PRIORITY JOURNAL; TISSUE OXYGENATION;

ANILINE COMPOUNDS; BETA-THALASSEMIA; CHLORIDES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FETAL HEMOGLOBIN; HUMANS; OXYGEN; OXYGEN CONSUMPTION; PROPIONIC ACIDS;

EID: 0031670490     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1998.00886.x     Document Type: Article

References (20)

1. Abraham, D.J., Wireko, F.C., Randad, R.S., Poyart, C., Kister, J., Bohn, B., Liard, J.-F. & Kunert, M.P. (1992) Allosteric modifiers of hemoglobin: 2-[4-][(3,5-disubstituted anilinolcarbonyl] methyl]-phenoxyl]-2-methylpropionic acid derivatives that lower the oxygen affinity of hemoglobin in red cell suspensions, in whole blood, and in vivo in rats. Biochemistry, 31, 9141-9149.
2. Adachi, K., Konitzer, P., Pang, J., Reddy, K.S. & Surrey, S. (1997) Amino acids responsible for decreased 2.3-biphosphoglycerate binding to fetal hemoglobin. Blood, 90, 2916-2920.
3. Arya, R., Rolan, P., Wootton, R., Posner, J. & Bellingham, A. (1996) Tucaresol increases oxygen affinity and reduces haemolysis in subjects with sickle cell anaemia. British Journal of Haematology, 99, 817-821.
4. Bunn, H. (1997) Pathogenesis and treatment of sickle cell disease. New England Journal of Medicine, 337, 762-769.
5. Doppenberg, K.M., Watson, J.C., Bullock, R., Gerber, M.J., Zauner, A. & Abraham, D.J. (1997) The rationale for and effects of oxygen delivery enhancement to ischemic brain in a feline model of human stroke. Annals of the New York Academy of Sciences, 825, 241-257.
6. Doyle, M.L., Gill, S.J., De Cristofaro, R., Castagnola, M. & Di Cera, E. (1989) Temperature and pH dependence of the oxygen binding reaction of human foetal hemoglobin. Biochemical Journal, 260, 617-619.
7. Giardina, B., Scatena, R., Clementi, M.E., Cerroni, L., Nuutinen, M., Brix, O., Sletten, S.N., Castagnola, M. & Condo, S.G. (1993) Physiological relevance of the overall AH of the oxygen binding to fetal human hemoglobin. Journal of Molecular Biology, 229, 512-516.
8. 2104(G6) Arg→Ser]. Hemoglobin, 13, 567-578.
9. Kister, J., Poyart, C. & Edelstein, S.J. (1987) An expanded two-state allosteric model for interaction of human hemoglobin A with non-saturating concentrations of 2,3-diphosphoglycerate. Journal of Biological Chemistry, 262, 12085-12091.
10. Kunert, M., Liard, J.-F. & Abraham, D.J. (1996) RSR-13, an allosteric effector of hemoglobin, increases systemic and iliac vascular resistance in rats. American Journal of Physiology, 40, H602-613.
11. Loukopoulos, D. (1997) New therapies for the haemoglobinopathies. Journal of Internal Medicine, 242, (Suppl. 740), 43-48.
12. Marden, M.C., Kister, J., Bohn, B. & Poyart, C. (1988) T-state hemoglobin with four ligands bound. Biochemistry, 27, 1659-1664.
13. Perutz, M.F., Fermi, G., Abraham, D.J., Poyart, C. & Bursaux, E. (1986) Hemoglobin as a receptor of drugs and peptides: X-ray studies of the stereochemistry of binding. Journal of the American Chemical Society, 108, 1064-1078.
14. Perutz, M.F., Fermi, G., Poyart, C., Pagnier, J. & Kister, J. (1993) A novel allosteric mechanism in haemoglobin: structure of bovine deoxyhaemoglobin, absence of specific chloride-binding sites and origin of the chloride-linked Bohr effect in bovine and human haemoglobin. Journal of Molecular Biology 233, 536-545.
15. Perutz, M.F. & Poyart, C. (1983) Bezafibrate lowers oxygen affinity of haemoglobin. Lancet, ii, 881-882.
16. Perutz, M.F., Shih, D.T.-B. & Williamson, D. (1994) The chloride effect in human haemoglobin: a new kind of allosteric mechanism. Journal of Molecular Biology, 239, 555-560.
17. Poyart, C., Marden, M.C. & Kister, J. (1994) Bezafibrate derivatives as potent effectors of hemoglobin. Methods in Enzymology, 232, 496-513.
18. Tomita, S. (1981) Modulation of the oxygen equilibria of human foetal and adult hemoglobins by 2.3-diphosphoglyceric acid. Journal of Biological Chemistry, 256, 9495-9500.
19. Venitz, J., Gerber, M. & Abraham, D. (1996) Pharmacological effects of escalating i.v. doses of an allosteric hemoglobin (Hb) modifier. RSR-13, in healthy vounteers. Pharmacology Research, 13, 115. Abstr.
20. Voskaridou, V. Kalotychou, V. & Loukopoulos, D. (1995) Clinical and laboratory effects of long-term administration of hydroxyurea to patients with sickle cell/β-thalassaemia. British Journal of Haematology, 89, 479-484.